Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |